Knee Replacement Systems for Osteoarthritis
Trial Summary
What is the purpose of this trial?
Patients with degenerative joint disease can effectively be treated with a primary total knee replacement to reduce pain and improve function in their daily lives. Theoretically, achievement of normal knee motion using a medial pivot design in total knee replacements can be recreated in comparison to single radius designs, which could lead to an improvement in post-surgical outcomes and satisfaction with the procedure. The aim of this study is to compare two types of implant designs (medial pivot and single radius) in a total knee replacement using clinical outcomes, patient reported outcomes, and overall function assessed by a specialized gait laboratory.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinator or your doctor.
What data supports the effectiveness of the treatment Knee Replacement Systems for Osteoarthritis?
Research shows that medial-pivot knee systems, like the ones used in this trial, are designed to mimic natural knee movement, which may improve stability and patient satisfaction. Studies have reported high success rates and positive mid- to long-term outcomes for these systems, suggesting they can be effective for knee replacement.12345
Is the knee replacement system generally safe for humans?
The medial pivot knee replacement design aims to mimic normal knee movement and has shown satisfactory mid-term safety outcomes, but more studies are needed to confirm long-term safety. The design has been used in various studies, and while it shows promise, comprehensive long-term safety data is still required.16789
How does the MicroPort Evolution Medial-Pivot Knee System differ from other knee replacement treatments for osteoarthritis?
The MicroPort Evolution Medial-Pivot Knee System is unique because it uses a 'ball-in-socket' design to mimic natural knee movement, aiming to improve stability and function by closely replicating the knee's natural motion. This design contrasts with traditional knee replacements that may not replicate the knee's natural kinematics as effectively.124510
Research Team
James Nace, MD
Principal Investigator
LifeBridge Health
Eligibility Criteria
This trial is for men and non-pregnant women aged 18-75 who need a knee replacement due to degenerative joint disease. They must be able to walk, attend follow-up visits, and not have had previous knee replacements or conditions that would affect walking tests.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Pre-operative assessments and baseline measurements are conducted
Operative
Total Knee Arthroplasty is performed using either the Medial Pivot or Single Radius design
Post-operative Follow-up
Participants are monitored for post-surgical outcomes and complications
Treatment Details
Interventions
- MicroPort Evolution Medial-Pivot Knee System (Cruciate-substituting)
- Stryker Triathlon Tritanium Knee System (Condylar Stabilizing)
MicroPort Evolution Medial-Pivot Knee System (Cruciate-substituting) is already approved in United States, European Union, Canada, Japan, Switzerland for the following indications:
- Degenerative joint disease
- Primary total knee replacement
- Degenerative joint disease
- Primary total knee replacement
- Degenerative joint disease
- Primary total knee replacement
- Degenerative joint disease
- Primary total knee replacement
- Degenerative joint disease
- Primary total knee replacement
Find a Clinic Near You
Who Is Running the Clinical Trial?
LifeBridge Health
Lead Sponsor
MicroPort Orthopedics Inc.
Industry Sponsor
Rubin Institute for Advanced Orthopedics
Collaborator